Elevance Health, Inc. — Director's Dealing 2021

Mar 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2021-03-22

Reporting Person: Haytaian Peter D (EVP & President, Commercial)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-22	Common Stock	M	15593	$146.93	Acquired	59544	Direct
2021-03-22	Common Stock	M	22500	$131.80	Acquired	82044	Direct
2021-03-22	Common Stock	S	300	$345.59	Disposed	81744	Direct
2021-03-22	Common Stock	S	9387	$347.44	Disposed	72357	Direct
2021-03-22	Common Stock	S	12416	$348.52	Disposed	59941	Direct
2021-03-22	Common Stock	S	26777	$349.53	Disposed	33164	Direct
2021-03-22	Common Stock	S	7891	$350.21	Disposed	25273	Direct
2021-03-22	Common Stock	S	400	$351.32	Disposed	24873	Direct
2021-03-22	Common Stock	S	2329	$352.84	Disposed	22544	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-22	Employee Stock Option (Right to Buy)	$146.93	M	15593	Disposed	2025-03-02	Common Stock (15593.0)	Direct
2021-03-22	Employee Stock Option (Right to Buy)	$131.8	M	22500	Disposed	2026-03-01	Common Stock (22500.0)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February, 1, 2021.

F2: This transaction was executed in multiple trades at prices ranging from $345.53 to $345.66. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $346.93 to $347.91. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $347.95 to $348.91. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $348.97 to $349.94. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This transaction was executed in multiple trades at prices ranging from $349.97 to $350.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: This transaction was executed in multiple trades at prices ranging from $350.99 to $351.54. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8: The option represents a right to purchase a total of 22,353 shares and is exercisable in six semi-annual installments, with three installments of 3,725 shares each and three installments of 3,726 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted

F9: The option represents a right to purchase a total of 24,348 shares, and is exercisable in six semi-annual installments of 4,058 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date.